ACTEL CORP
10-Q, 2000-11-13
SEMICONDUCTORS & RELATED DEVICES
Previous: OPTICAL SENSORS INC, 10-Q, EX-27, 2000-11-13
Next: MB FINANCIAL INC, 10-Q, 2000-11-13





                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                     --------------------------------------

                                    FORM 10-Q

(Mark One)

    X     QUARTERLY  REPORT  PURSUANT  TO SECTION 13 OR 15(d) OF THE  SECURITIES
          EXCHANGE ACT OF 1934

For the quarterly period ended October 1, 2000

                                       OR

          TRANSITION  REPORT  PURSUANT TO SECTION 13 OR 15(d) OF THE  SECURITIES
          EXCHANGE ACT OF 1934

Commission file number 0-21970

                     --------------------------------------

                                ACTEL CORPORATION
             (Exact name of Registrant as specified in its charter)

                California                                      77-0097724
      (State or other jurisdiction of                        (I.R.S. Employer
      incorporation or organization)                       Identification No.)

          955 East Arques Avenue
           Sunnyvale, California                                94086-4533
 (Address of principal executive offices)                       (Zip Code)

                                 (408) 739-1010
              (Registrant's telephone number, including area code)

                     --------------------------------------

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  Registrant  was
required  to file  such  reports)  and  (2)  has  been  subject  to such  filing
requirements for the past 90 days. X Yes No

     Number of shares  of Common  Stock  outstanding  as of  November  3,  2000:
24,121,223.

<PAGE>


                         PART I -- FINANCIAL INFORMATION

Item 1.       Financial Statements.



                                ACTEL CORPORATION

                   CONSOLIDATED CONDENSED STATEMENTS OF INCOME
               (unaudited, in thousands except per share amounts)

<TABLE>
<CAPTION>
                                                          Three Months Ended              Nine Months Ended
                                                 -----------------------------------    ----------------------
                                                  Oct. 1,      Oct. 3,      Jul. 2,      Oct. 1,      Oct. 3,
                                                   2000         1999         2000         2000         1999
                                                 ---------    ---------    ---------    ---------    ---------
<S>                                              <C>          <C>          <C>          <C>          <C>
Net revenues .................................   $  60,080    $  43,162    $  55,544    $ 166,290    $ 125,619
Costs and expenses:
   Cost of revenues ..........................      22,454       16,659       20,949       62,611       48,891
   Research and development ..................       9,325        7,740        8,888       26,564       24,251
   Selling, general, and administrative ......      12,329       10,921       11,827       35,685       34,266
   Amortization of goodwill and other
     acquisition-related intangibles .........       2,324          350        1,544        4,891        1,179
   Restructure and other charges .............        --           --           --           --          1,963
   Purchased in-process research and
     development .............................        --           --          5,558        5,558         --
                                                 ---------    ---------    ---------    ---------    ---------
         Total costs and expenses ............      46,432       35,670       48,766      135,309      110,550
                                                 ---------    ---------    ---------    ---------    ---------
Income from operations .......................      13,648        7,492        6,778       30,981       15,069
Interest income and other, net ...............       2,691          941        1,859        5,855        2,403
Gain on sale of Chartered Common stock .......        --           --         28,329       28,329         --
                                                 ---------    ---------    ---------    ---------    ---------
Income before tax provision and equity in net
  loss of equity method investee .............      16,339        8,433       36,966       65,165       17,472
Equity in net (loss) of equity method investee        (922)        (217)        (356)      (1,401)        (217)
Tax provision ................................       5,638        2,548       16,498       25,774        5,440
                                                 ---------    ---------    ---------    ---------    ---------
Net income ...................................   $   9,779    $   5,668    $  20,112    $  37,990    $  11,815
                                                 =========    =========    =========    =========    =========

Net income per share:
   Basic .....................................   $    0.41    $    0.26    $    0.86    $    1.63    $    0.55
                                                 =========    =========    =========    =========    =========
   Diluted ...................................   $    0.36    $    0.25    $    0.77    $    1.45    $    0.52
                                                 =========    =========    =========    =========    =========

Shares used in computing net income per share:
   Basic .....................................      23,869       21,748       23,263       23,300       21,535
                                                 =========    =========    =========    =========    =========
   Diluted ...................................      26,999       23,003       26,186       26,207       22,711
                                                 =========    =========    =========    =========    =========
</TABLE>

<PAGE>
                                ACTEL CORPORATION

                      CONSOLIDATED CONDENSED BALANCE SHEETS
                                 (in thousands)

                                                          Oct. 1,      Jan. 2,
                                                           2000         2000
                                                         ---------    ---------
                                                        (unaudited)
                                     ASSETS
Current assets:
   Cash and cash equivalents .........................   $  14,062    $   4,939
   Short-term investments ............................     161,624      102,201
   Accounts receivable, net ..........................      25,799       22,753
   Inventories, net ..................................      26,486       25,324
   Deferred income taxes .............................      21,378       20,622
   Prepaid expenses and other current assets .........       2,054        2,045
                                                         ---------    ---------
         Total current assets ........................     251,403      177,884
Property and equipment, net ..........................      11,014       12,564
Investment in Chartered Semiconductor ................        --         37,619
Other assets, net ....................................      48,062       31,144
                                                         ---------    ---------
                                                         $ 310,479    $ 259,211
                                                         =========    =========

                      LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:
   Accounts payable ..................................   $  11,616    $  15,374
   Accrued salaries and employee benefits ............      13,844        6,884
   Other accrued liabilities .........................       3,501        2,887
   Income taxes payable ..............................       6,457        4,025
   Deferred income ...................................      42,365       39,896
                                                         ---------    ---------
         Total current liabilities ...................      77,783       69,066
   Deferred tax liability ............................         949       11,515
                                                         ---------    ---------
         Total liabilities ...........................      78,732       80,581
Commitments and contingencies
Shareholders' equity:
   Common stock ......................................          24           22
   Additional paid-in capital ........................     141,535      110,146
   Accumulated earnings ..............................      90,390       52,401
   Note receivable from officer ......................        (368)        --
   Accumulated other comprehensive income ............         166       16,061
                                                         ---------    ---------
         Total shareholders' equity ..................     231,747      178,630
                                                         ---------    ---------
                                                         $ 310,479    $ 259,211
                                                         =========    =========

<PAGE>


                                ACTEL CORPORATION

                 CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
                            (unaudited, in thousands)


                                                            Nine Months Ended
                                                         ----------------------
                                                          Oct. 1,      Oct. 3,
                                                            2000         1999
                                                         ---------    ---------
Operating activities:
   Net income ........................................   $  37,990    $  11,815
   Adjustments  to  reconcile  net  income  to net
   cash  provided  by  operating activities:
     Depreciation and amortization ...................      10,598        7,165
     Non-cash portion of restructure and other charges        --          3,057
     Equity in net loss of equity method investee ....       1,401          217
     Gain on sale of Chartered Semiconductor stock ...     (28,329)        --
     Purchased in-process research and development ...       5,558         --
     Changes in operating assets and liabilities:
       Accounts receivable ...........................      (3,046)      (4,534)
       Inventories ...................................      (1,162)       2,816
       Other current assets ..........................           4          305
       Accounts payable, accrued salaries and employee
         benefits, and other accrued liabilities .....       6,016         (843)
       Deferred income ...............................       2,469        2,713
       Deferred income taxes .........................        (976)         347
                                                         ---------    ---------
   Net cash provided by operating activities .........      30,523       23,058
                                                         ---------    ---------
Investing activities:
   Purchases of property and equipment ...............      (4,157)      (4,539)
   Purchases of available-for-sale securities ........    (288,476)    (131,708)
   Sales of available-for-sale securities ............     229,502      113,449
   Other assets ......................................        (304)      (2,197)
   Proceeds from sale of Chartered Semiconductor
     common stock ....................................      39,009         --
   Cash paid for purchase of Prosys ..................      (6,857)        --
   Note receivable from GateField ....................      (3,750)      (8,000)
                                                         ---------    ---------
   Net cash used in investing activities .............     (35,033)     (32,995)
                                                         ---------    ---------

Financing activities:
   Issuance of note receivable from officer ..........        (368)        --
   Sale of common stock ..............................      14,001        5,864
                                                         ---------    ---------
   Net cash provided by financing activities .........      13,633        5,864
                                                         ---------    ---------
Net decrease in cash and cash equivalents ............       9,123       (4,073)
Cash and cash equivalents, beginning of period .......       4,939       13,947
                                                         ---------    ---------
Cash and cash equivalents, end of period .............   $  14,062    $   9,874
                                                         =========    =========

<PAGE>
Supplemental disclosures of cash flow information:
   Cash paid for taxes ...............................   $  24,314    $   8,193

Supplemental disclosures of non-cash transactions:
Issuance of common stock in conjunction with Prosys
  acqusition ..........................................  $   7,526        --
Conversion of $8.0 million GateField Promissory Note
  into 1,230,769 shares of GateField common stock.
Conversion of 300,000  shares of GateField  Series C
  Preferred  Stock with an adjusted cost basis of $1.3
  million into 200,000 shares of GateField common
  stock.

1.       Basis of Presentation and Summary of Significant Accounting Policies

         The accompanying  unaudited  consolidated financial statements of Actel
Corporation  ("Actel" or "the  Company")  have been prepared in accordance  with
generally accepted accounting  principles for interim financial  information and
with  the   instructions  to  Form  10-Q  and  Article  10  of  Regulation  S-X.
Accordingly,  these  financial  statements do not include all of the information
and footnotes required by generally accepted accounting  principles for complete
financial statements. In the opinion of management,  all adjustments (consisting
of normal recurring accruals)  considered necessary for a fair presentation have
been included.

         The  consolidated  financial  statements  include  the  accounts of the
Company and its wholly owned subsidiaries. All significant intercompany accounts
and transactions  have been eliminated in  consolidation.  The interim financial
statements should be read in conjunction with the audited  financial  statements
included in the Company's  Annual Report on Form 10-K for the year ended January
2, 2000.  The results of operations  for the three and nine months ended October
1, 2000, are not necessarily  indicative of results that may be expected for the
entire year ending December 31, 2000.

2.       Recent Accounting Pronouncements

         In June 1998, the Financial Accounting Standards Board issued Statement
of Financial  Accounting  Standards  (SFAS) No. 133,  "Accounting for Derivative
Instruments and Hedging  Activities,"  which, as amended by SFAS 137 and 138, is
required to be adopted in years beginning after June 15, 2000.  Actel will adopt
SFAS 133 for the first quarter of fiscal 2001. SFAS 133 requires all derivatives
to be carried on the balance sheet at fair value. Under SFAS 133, changes in the
derivatives' fair value must be recognized currently in earnings unless specific
hedge  accounting  criteria  are  met  and a  company  must  formally  document,
designate,  and assess the  effectiveness  of  transactions  that receive  hedge
accounting.  The Company has  evaluated the impact of adopting SFAS 133 and does
not  expect  adoption  to have a  material  effect  on the  Company's  financial
position or results of operations.

         In March 2000, the Financial  Accounting  Standards Board (FASB) issued
FASB Interpretation (FIN) No. 44, "Accounting for Certain Transactions Involving
Stock  Compensation." FIN 44 clarifies the application of Accounting  Principles
Board Opinion No. 25 for certain issues relating to stock  compensation.  FIN 44
is effective July 1, 2000, but certain  conclusions in it cover specific  events
that occur after either  December 15, 1998,  or January 12, 2000.  To the extent
that FIN 44 covers events  occurring  during the period after December 15, 1998,
or January 12, 2000,  but before the effective date of July 1, 2000, the effects
of applying FIN 44 are recognized on a prospective  basis from July 1, 2000. The
Company  has  adopted  FIN 44 and  there  has  been no  material  effect  on its
financial position or results of operations.

         In December 1999, the Securities and Exchange  Commission  (SEC) issued
SEC Staff Accounting  Bulletin (SAB) No. 101, "Revenue  Recognition in Financial
Statements." SAB 101 summarizes certain of the SEC's views in applying generally
accepted accounting  principles to revenue recognition in financial  statements.
The Company believes that its current revenue  recognition  policy is consistent
with the guidance of SAB 101.

3.       Equity Accounting

         In  light of  Actel's  investments  in and  agreements  with  GateField
Corporation ("GateField"), including common stock, convertible promissory notes,
and marketing and licensing  agreements,  Actel accounts for its  investments in
GateField under the equity method of accounting.  Actel began accounting for its
equity interest in GateField under the equity method of accounting  during 1999.
For the third quarter of fiscal 2000, equity accounting  resulted in a charge of
$1,709,000 to the Company's net income,  consisting of $787,000 in  amortization
of goodwill and $922,000 in equity in net losses of equity method investee.

         During the quarter ended October 1, 2000, the Company loaned  GateField
$2.75 million in exchange for a promissory  note that bears interest at the rate
of 6.25% per year and is  convertible  into 523,810  shares of GateField  common
stock.  At October 1, 2000,  the Company  owned  1,622,298  shares of  GateField
common stock.  Assuming  conversion of all promissory  notes due from GateField,
the aggregate total of GateField  common stock owned by Actel would be 2,336,584
shares, or 33.9% of the total common stock of GateField. GateField common stock,
which is  listed  on the  National  Association  of  Security  Dealers  ("NASD")
Over-The-Counter Bulletin Board, closed at $4.8125 on September 29, 2000.

         On May 31,  2000,  GateField  and  Actel  announced  the  signing  of a
definitive agreement to merge. In the merger, Actel would pay cash consideration
of $5.25 for each share of  GateField  common  stock not already  owned by Actel
(approximately  4.5 million  shares).  Actel  would also assume all  outstanding
GateField stock options. The merger is subject to several conditions,  including
approval by GateField  stockholders at a special meeting currently scheduled for
November 10, 2000.

<PAGE>

4.       Inventories

         Inventories consist of the following:

                                                        Oct. 1,      Jan. 2,
                                                         2000          2000
                                                      -----------   -----------
                                                             (in thousands)
Inventories:
   Purchased parts and raw materials..............    $     4,820   $     3,363
   Work-in-process................................         11,830         8,366
   Finished goods.................................          9,836        13,595
                                                      -----------   -----------
                                                      $    26,486   $    25,324
                                                      ===========   ===========

         Inventories  are stated at the lower of cost  (first-in,  first-out) or
market  (net  realizable  value).  Given the  volatility  of the  market for the
Company's  products,  the Company makes  inventory  provisions  for  potentially
excess and obsolete  inventory  based on backlog and forecast  demand.  However,
such backlog demand is subject to revisions,  cancellations,  and  rescheduling.
Actual demand will inevitably differ from such backlog and forecast demand,  and
such differences may be material to the financial  statements.  Excess inventory
increases  handling costs and the risk of obsolescence,  is a non-productive use
of  capital  resources,  and  delays  realization  of the price and  performance
benefits associated with more advanced manufacturing processes.


5.       Earnings Per Share

         The  following  table sets forth the  computation  of basic and diluted
earnings  per  share  in  accordance  with  Statement  of  Financial  Accounting
Standards No. 128, "Earnings per Share":

<TABLE>
<CAPTION>
                                                     Three Months Ended       Nine Months Ended
                                                ---------------------------   -----------------
                                                Oct. 1,   Oct. 3,   Jul. 2,   Oct. 1,   Oct. 3,
                                                  2000      1999      2000      2000      1999
                                                -------   -------   -------   -------   -------
                                                    (in thousands, except per share amounts)
<S>                                             <C>       <C>       <C>       <C>       <C>
Basic:
Average common shares outstanding ...........    23,869    21,748    23,263    23,300    21,535
Shares used in computing net income per share    23,869    21,748    23,263    23,300    21,535
                                                =======   =======   =======   =======   =======
Net income ..................................   $ 9,779   $ 5,668   $20,112   $37,990   $11,815
                                                =======   =======   =======   =======   =======
Net income per share ........................   $  0.41   $  0.26   $  0.86   $  1.63   $  0.55
                                                =======   =======   =======   =======   =======

Diluted:
Average common shares outstanding ...........    23,869    21,748    23,263    23,300    21,535
Net effect of dilutive stock options - based
   on the treasury stock method .............     3,130     1,255     2,923     2,907     1,176
                                                -------   -------   -------   -------   -------
Shares used in computing net income per share    26,999    23,003    26,186    26,207    22,711
                                                =======   =======   =======   =======   =======
Net income ..................................   $ 9,779   $ 5,668   $20,112   $37,990   $11,815
                                                =======   =======   =======   =======   =======
Net income per share ........................   $  0.36   $  0.25   $  0.77   $  1.45   $  0.52
                                                =======   =======   =======   =======   =======
</TABLE>


6.       Comprehensive Income

         The components of comprehensive income, net of tax, are as follows:

<TABLE>
<CAPTION>
                                                         Three Months Ended            Nine Months Ended
                                                  -------------------------------    --------------------
                                                   Oct. 1,    Oct. 3,     Jul. 2,     Oct. 1,     Oct. 3,
                                                    2000       1999        2000        2000        1999
                                                  --------   --------    --------    --------    --------
                                                                            (in thousands)

<S>                                               <C>        <C>         <C>         <C>         <C>
Net Income ....................................   $  9,779   $  5,668    $ 20,112    $ 37,990    $ 11,815
Change in gain on available-for-sale securities        506        (23)     (5,738)      1,283        (175)
Less reclassification adjustment for (gains)
   losses included in net income ..............       --         --       (17,189)    (17,178)       --
                                                  --------   --------    --------    --------    --------
Other Comprehensive Income (Loss) .............        506        (23)    (22,927)    (15,895)       (175)
                                                  --------   --------    --------    --------    --------
Total Comprehensive Income (Loss) .............   $ 10,285   $  5,645    $ (2,815)   $ 22,095    $ 11,640
                                                  ========   ========    ========    ========    ========
</TABLE>

Accumulated   other   comprehensive   income   presented  in  the   accompanying
consolidated condensed balance sheets consists of the accumulated net unrealized
gain (loss) on available-for-sale securities.

7.       Infringement Claims

         Periodically,  the  Company is made aware that  technology  used by the
Company may infringe  intellectual  property  rights held by others.  During the
third quarter of fiscal 2000, the Company continued in negotiations with several
third parties regarding  potential patent  infringement  issues. The Company has
made adequate provision for the estimated settlement costs of claims for alleged
infringement  prior to the balance sheet date.  While  management  believes that
reasonable  resolution  will occur,  there can be no assurance that these claims
will be  resolved  or that  the  resolution  of  these  claims  will  not have a
materially  adverse effect on future results of operations or require changes in
the Company's products or processes. In addition, management's evaluation of the
likely impact of these pending  disputes could change based upon new information
learned by management. Subject to the foregoing, management does not believe any
pending dispute,  including the legal proceeding  described below, are likely to
have a materially adverse effect on the Company's financial  condition,  results
of  operations,  or  liquidity.  The  foregoing is a  forward-looking  statement
subject to all of the risks and uncertainties of intellectual  property disputes
and  legal   proceedings,   including  the  discovery  of  new  information  and
unpredictability as to the ultimate outcome.

         On March 29, 2000, Unisys Corporation brought suit in the United States
District  Court for the  Northern  District of  California,  San Jose  Division,
against the Company  seeking  monetary  damages and  injunctive  relief based on
Actel's  alleged  infringement  of four patents held by Unisys.  In the lawsuit,
Unisys  alleges that the Company has  infringed  and  continues to infringe four
Unisys  patents and seeks  damages,  costs and  attorneys'  fees,  as well as an
injunction prohibiting further infringement.  On May 11, 2000, the Company filed
its answer  and  counterclaim  in which it denies  that it has  infringed  or is
infringing any of the asserted  patents,  and seeks a judicial  declaration that
the  asserted  patents  are  invalid  and  unenforceable.  Trial has been set to
commence  on March  25,  2002.  The  Company  believes  that it has  meritorious
defenses  to the  claims  asserted  by  Unisys  and  intends  to  defend  itself
vigorously in this matter.

8.       Prosys Technology Acquisition

         In  June  2000,  the  Company   completed  the  acquisition  of  Prosys
Technology,  Inc.  ("Prosys"),  a developer of embedded field  programmable gate
array ("FPGA")  intellectual  property ("IP") cores, in a transaction  accounted
for as a purchase. In connection with the acquisition, the Company accrued for a
cash payment of $6,900,000 to be made to Prosys  shareholders and issued 220,518
shares of Actel  common  stock,  which  were  valued at $34.13  per  share.  The
valuation  of the common  stock was based on an average  of the  closing  market
prices for Actel common  stock on the two days  before,  the day of, and the two
days after the  agreement  to acquire  Prosys was  announced.  The Company  also
assumed  $144,000 of liabilities,  incurred  $88,000 of acquisition  costs,  and
assumed  existing Prosys  options,  which were converted into options to acquire
Actel common  stock.  These  options were fully vested and valued at  $9,864,000
using the Black-Scholes  Option Pricing Model. Thus, total consideration for the
Prosys acquisition was valued at $24,522,000.

         In  accordance  with the  provisions  of  Accounting  Principles  Board
Opinion No. 16, "Business Combinations", all identifiable assets were assigned a
portion of the total consideration on the basis of their respective fair values.
The  consideration  was allocated as follows based on the valuation report of an
independent valuation specialist:

                  In-process research and development         $ 5,558,000
                  Acquired work-force                             273,000
                  Patent applications                             349,000
                  Cash & other current assets                      57,000
                  Deferred tax liability                         (249,000)
                  Goodwill and other intangibles               18,534,000

         A  portion  of the  purchase  price  has  been  allocated  to  acquired
in-process  research and  development  ("IPRD").  IPRD was identified and valued
through  extensive  interviews,  analysis of data provided by Prosys  concerning
developmental  products,  their  stage of  development,  the time and  resources
needed to complete them, and associated risks. The income approach,  which bases
the value of an asset on future earnings  capacity of the asset, was utilized in
valuing the IPRD.  This approach  values an asset based on the future cash flows
that could be potentially generated by the asset over its estimated useful life.
The future cash flows are discounted to their present value utilizing a discount
rate (25%) that would  provide  sufficient  return to a  potential  investor  to
estimate the value of the subject asset.  The estimated  completion  date of the
technology  is late 2000.  The present  value of the cash flows over the life of
the asset is summed to equal the estimated value of the asset. The IPRD,  valued
at $5,558,000 using the income approach, was charged to expense upon the closing
of the acquisition.

         The  value  of the  assembled  workforce  was  estimated  using  a cost
approach.  This approach identifies the employees that would require significant
cost to replace and train. This analysis then estimates the fully burdened costs
(locating,  interviewing,  and hiring) attributed to each employee.  These costs
are summed up and tax-effected to estimate the value of the estimated workforce.
The Company expects to amortize the value assigned to the acquired  workforce of
$273,000 on a straight-line basis over an estimated remaining useful life of six
months.

         As of the  valuation  date,  it was  assumed  that there was some value
attributable   to  the  Prosys   patent   applications.   To  value  the  patent
applications, the relief from royalty methodology was utilized. This methodology
assumes that the value of the asset equals the amount a third party would pay to
use the asset and capitalize on the related benefits of the asset.  Therefore, a
revenue stream for the asset is estimated,  and then an appropriate royalty rate
is applied to the forecasted  revenue to estimate the pre-tax income  associated
with the  asset.  The  pre-tax  income  is then  tax-effected  to  estimate  the
after-tax  net income  associated  with the asset.  Finally,  the  after-tax net
income is discounted to the present  value using an  appropriate  rate of return
(25%) that  considers  both the risk of the asset and the  associated  cash flow
estimates.  The  Company  expects to amortize  the value  assigned to the patent
applications of $349,000 on a straight-line  basis over an estimated useful life
of five years.

         Goodwill,  which  represents  the  excess of the  purchase  price of an
investment  in an acquired  business over the fair value of the  underlying  net
identifiable  assets,  is amortized on a straight-line  basis over its estimated
useful life of five years.


         The following  unaudited pro forma results of operations  for the third
quarter and nine months  ending  October 1, 2000,  are  presented  are as if the
acquisition  of Prosys had occurred as of the  beginning  of 1999,  and includes
certain estimated adjustments (including  amortization of intangibles).  The pro
forma  results  exclude the  one-time  write-off  of  $5,558,000  of  in-process
research  and  development  and the tax  effect  of the  charge.  The  pro-forma
information has been prepared for comparative purposes only and does not purport
to be indicative of what  operating  results would have been if the  acquisition
had  actually  taken  place  at the  beginning  of 1999 or of  future  operating
results.


                                  Three Months Ended     Nine Months Ended
                                  -------------------   -------------------
                                   Oct. 1,    Oct. 3,    Oct. 1,    Oct. 3,
                                  --------   --------   --------   --------
                                   (in thousands, except per share amounts)

Net revenues ..................   $ 60,080   $ 43,162   $166,290   $125,619
Net income ....................      9,916      4,273     41,554      7,355
Diluted earnings per share ....       0.37       0.18       1.57       0.32

9.       Subsequent Events

         On October 2, 2000, the Company made a $2.2 million  equity  investment
in Elixent Limited, a developer of IP. The Actel investment  represents 13.5% of
the equity share capital of Elixent on a fully diluted basis.

         On October 6, 2000,  Actel loaned  GateField  $3.25 million in exchange
for a promissory  note that is  convertible  into  GateField  common stock at an
effective rate of $5.25 per share.



<PAGE>




Item 2. Management's  Discussion and Analysis of Financial Condition and Results
          of Operations.

         All  forward-looking  statements  contained in this Quarterly Report on
Form 10-Q,  including all forward-looking  statements  contained in any document
incorporated  herein  by  reference,  are  made  pursuant  to  the  safe  harbor
provisions of the Public Securities Litigation Reform Act of 1995. Words such as
"anticipates,"  "believes,"  "estimates," "expects," intends," "plans," "seeks,"
and  variations of such words and similar  expressions  are intended to identify
the forward-looking  statements. In addition, all forward-looking statements are
based on current  expectations and projections about the semiconductor  industry
and programmable logic market, and assumptions made by the Company's  management
that  reflect  its  best  judgment  based on other  factors  currently  known by
management,  but they are not  guarantees  of future  performance.  Accordingly,
actual events and results may differ materially from those expressed or forecast
in the  forward-looking  statements due to the risk factors identified herein or
for other reasons. The Company undertakes no obligation to update any statement,
including any forward-looking statement,  contained or incorporated by reference
in this Quarterly Report on Form 10-Q.

Results of Operations

         Net Revenues

         Net revenues  for the third  quarter of fiscal 2000 were a record $60.1
million,  which  represents  an increase of 8% compared  with the  Company's net
revenues for the second  quarter of fiscal 2000 of $55.5 million and an increase
of 39% compared  with the Company's net revenues for the third quarter of fiscal
1999 of $43.2 million.  Quarterly net revenues  increased  sequentially due to a
17% increase in the overall average selling price ("ASP") of FPGAs that resulted
primarily from increased  sales of the Company's newer product  families,  which
was partially offset by a 7% decrease in unit shipments.

         Net  revenues  for the first  nine  months of fiscal  2000 were  $166.3
million,  which  represents  an increase of 32% compared  with the Company's net
revenues for the first nine months of fiscal 1999. Net revenues increased as the
result of a 27% increase in unit shipments and a 5% increase in ASPs.

         Gross Margin

         Gross margin for the third quarter of fiscal 2000 was a record 62.6% of
net  revenues,  compared  with 62.3% for the second  quarter of fiscal  2000 and
61.4% for the third  quarter  of fiscal  1999.  Gross  margin for the first nine
months of fiscal  2000 was 62.3% of net  revenues,  compared  with  61.1% of net
revenues  for the first  nine  months  of fiscal  1999.  Gross  margin  improved
primarily as a result of improved yields, especially on newer products.

         The Company seeks to improve gross margin by reducing costs. These cost
reduction   activities   include  improving  wafer  yields,   negotiating  price
reductions  with  suppliers,  increasing the level and efficiency of its testing
and  packaging  operations,  achieving  economies  of scale  by means of  higher
production  levels,  and  increasing  the  number of die  produced  per wafer by
shrinking  the die size of its  products.  There can be no assurance  that these
efforts will be successful. The ability of the Company to shrink the die size of
its  FPGAs is  dependent  on the  availability  of more  advanced  manufacturing
processes.  Because of the custom steps involved in manufacturing antifuse-based
FPGAs, the Company typically obtains access to new manufacturing processes later
than its competitors using standard manufacturing processes.

         Research and Development

         Research and development  expenditures  for the third quarter of fiscal
2000 were $9.3 million,  or 16% of net revenues,  compared with $8.9 million, or
16% of net revenues,  for the second quarter of fiscal 2000 and $7.7 million, or
18% of revenues,  for the third quarter of fiscal 1999. Spending on research and
development  increased in the third quarter of fiscal 2000 primarily as a result
of the  Company's  acquisition  in June  2000 of  Prosys,  an  embedded  FPGA IP
developer.  The third  quarter  of fiscal  2000 was the first  full  quarter  to
include the Prosys incremental spending.

         Research  and  development  expenditures  for the first nine  months of
fiscal 2000 were $26.6  million,  or 16% of net  revenues,  compared  with $24.3
million, or 19% of net revenues,  for the first nine months of fiscal 1999. This
represents an increase of 10% in research and development expenditures, compared
with an increase of 32% in net revenues  during the same time  period.  Spending
increased   because  of  the  Prosys   acquisition  and  increased  new  product
development actvities.

         Selling, General, and Administrative

         Selling,  general, and administrative expenses for the third quarter of
fiscal 2000 were $12.3  million,  or 21% of net  revenues,  compared  with $11.8
million, or 21% of net revenues, for the second quarter of fiscal 2000 and $10.9
million, or 25% of net revenues,  for the third quarter of fiscal 1999. Selling,
general,  and  administrative  expenses  for the third  quarter  of fiscal  2000
increased  from the second  quarter of fiscal 2000 due  principally to increased
sales cost associated with the higher revenue.  Spending in the third quarter of
fiscal 2000  increased  over the same  quarter one year ago because of increased
marketing  activities in support of new products and increased  selling expenses
associated with higher revenue generation.

         Selling, general, and administrative expenses for the first nine months
of fiscal 2000 were $35.7 million,  or 21% of net revenues,  compared with $34.3
million, or 27% of net revenues, for the first nine months of fiscal 1999.

         Acquired In-Process Research and Development Expenses

         In June 2000,  the Company  completed  its  acquisition  of Prosys in a
transaction accounted for as a purchase. The in-process research and development
expense  associated  with this  purchase  resulted in a one-time  charge of $5.6
million during the second quarter of fiscal 2000.

         Amortization of Goodwill, Other  Acquisition-Related  Intangibles,  and
Other Acquisition-Related Expenses

         Amortization of goodwill and other acquisition-related expenses for the
third  quarter of fiscal 2000 was $2.3  million,  compared with $1.5 million for
the second  quarter of fiscal  2000 and $0.4  million  for the third  quarter of
fiscal 1999. The increase in the third quarter over the prior quarter was due to
a full quarter of amortization for the Prosys  acquisition,  which occurred late
in the second  quarter of fiscal  2000.  The  increase  in the third  quarter of
fiscal 2000 over the third  quarter in fiscal 1999 was due primarily to goodwill
amortization  charges of $1.1 million  arising from the Prosys  acquisition  and
equity method of accounting  charges of $0.8 million  arising from the Company's
investments in GateField.

         Amortization of goodwill and other acquisition-related  intangibles for
the first  nine  months  of fiscal  2000 was $4.9  million,  compared  with $1.2
million  for the first  nine  months  of  fiscal  1999.  This  increase  was due
primarily to goodwill amortization charges of $1.4 and $1.1 million arising from
the Company's acquisitions of Prosys in the second quarter of fiscal 2000 and of
AutoGate  Logic,  Inc. in the fourth quarter of fiscal 1999,  respectively,  and
equity method of accounting  charges of $1.9 million  arising from the Company's
investments in GateField. The first nine months of fiscal 1999 included goodwill
amortization  charges of $0.7 million arising from the Company's  acquisition of
Texas  Instrument's  FPGA  business in 1995,  which was fully  amortized  during
fiscal 1999.

         Gain on Sale of Chartered Common Stock

         During the second  quarter of fiscal 2000,  the Company sold all of its
shares of  Chartered  Semiconductor  common  stock for a one-time  gain of $28.3
million.

         Interest Income and Other Income and Expenses

         Interest  income and other income and expenses was $2.7 million for the
third quarter of fiscal 2000, compared with $1.9 million in the previous quarter
and $0.9 million in the third quarter one year ago. For the first nine months of
fiscal 2000,  interest and other income and expenses was $5.9 million,  compared
with $2.4 million  during the first nine months of fiscal 1999.  The increase in
both instances was driven by increased  cash, cash  equivalents,  and short-term
investments available for investing by the Company.

         Equity in Net Loss of Equity Method Investee

         In light of Actel's investments in and agreements with GateField, Actel
accounts for its investments in GateField under the equity method of accounting.
Actel began  accounting  for its equity  interest in GateField  under the equity
method of accounting  during 1999. During the quarter ended October 1, 2000, the
Company loaned  GateField  $2.75 million in exchange for a promissory  note that
bears  interest at the rate of 6.25% per year and is  convertible  into  523,810
shares of  GateField  common  stock.  At  October  1, 2000,  the  Company  owned
1,622,298 shares of GateField common stock.

         In light of this  investment,  the  Company  incurred  a charge of $0.9
million in the third  quarter of fiscal 2000  compared  with $0.4 million in the
prior  quarter and $0.2 million in the third  quarter one year ago. The increase
in the  charge to the  Company's  net income  for third  quarter of fiscal  2000
compared  with the prior  quarter was the result of an increase in the quarterly
loss of  GateField.  Compared with the same quarter one year ago, the charge was
higher due to an increase in the Company's  ownership of GateField  common stock
from 4.1% to 26.3%.

         Tax Provision

         The  Company's  effective  rate for the  three  and nine  months  ended
October  1,  2000  was  32%,  excluding  the  effect  of  certain  non-recurring
acquisition-related  charges  and  investment  gains.  The  effective  tax rates
including  such charges and gains for the three and nine months ended October 1,
2000, were 37% and 40%,  respectively.  The effective tax rates are based on the
estimated  annual tax rate in compliance with Statement of Financial  Accounting
Standards  No. 109,  "Accounting  for Income  Taxes." This rate differs from the
federal  statutory  rate due  primarily  to state  income  taxes (net of federal
benefit),  the benefits of research and development  credits, tax exempt income,
and recognition of certain  deferred tax assets subject to valuation  allowances
as of January 2, 2000.

Liquidity and Capital Resources

         At the end of the third  quarter of fiscal 2000,  the  Company's  cash,
cash equivalents,  and short-term investments were $175.7 million, compared with
$107.1  million at the  beginning  of fiscal  2000.  The amount of cash and cash
equivalents increased principally because of the sale of Chartered Semiconductor
common stock ($39.0 million cash  proceeds),  cash provided by  operations,  and
cash received from employee stock option transactions.

         During the first  nine  months of 2000,  the  Company  generated  $30.5
million of cash from  operating  activities.  The Company used $35.0  million of
cash in  investing  activities  during the first nine months of 2000.  Investing
activities   included   $59.0  million  net   purchases  of   available-for-sale
securities,  the  purchase  of Prosys  for $6.9  million,  the  purchase  of two
promissory notes from GateField totaling $3.8 million, and purchases of property
and equipment of $4.2 million.  These investing  purchases were partially offset
by $39.0  million of proceeds  from the sale of Chartered  Semiconductor  common
stock.  Financing  activities during the first nine months of 2000 provided cash
of $13.6  million,  which was  generated  primarily  from proceeds from sales of
common stock under employee option and stock purchase plans.

         The  Company  has a  line  of  credit  with a bank  that  provides  for
borrowings  not to exceed  $5,000,000.  The agreement  contains  covenants  that
require  the  Company to  maintain  certain  financial  ratios and levels of net
worth.  As of October 1, 2000, the Company was in compliance  with the covenants
for the line of credit.  Borrowings  against the line of credit bear interest at
the bank's prime rate.  There were no  borrowings  against the line of credit at
October  1,  2000.  The  line of  credit,  which  expires  in May  2001,  may be
terminated by either party upon not less than thirty days' prior written notice.

         The  Company  believes  that  existing  cash,  cash  equivalents,   and
short-term investments,  together with cash from operations,  will be sufficient
to meet its cash requirements for the next four quarters. A portion of available
cash may be used for investment in or acquisition of  complementary  businesses,
products,  or  technologies.  Wafer  manufacturers  are  increasingly  demanding
financial  support from customers in the form of equity  investments and advance
purchase price  deposits,  which in some cases are  substantial.  If the Company
requires  additional   capacity,   it  may  be  required  to  incur  significant
expenditures to secure such capacity.

         The  Company  believes  that the  availability  of  adequate  financial
resources  is  a  substantial   competitive   factor.   To  take   advantage  of
opportunities as they arise, or to withstand adverse business  conditions should
they  occur,  it may  become  prudent  or  necessary  for the  Company  to raise
additional capital.  The Company intends to continue monitoring the availability
and cost of potential capital resources, including equity, debt, and off-balance
sheet financing  arrangements,  and may consider raising  additional  capital on
terms  that are  acceptable  to the  Company.  There  can be no  assurance  that
additional capital will become available on acceptable terms, if at all.

Other Factors Affecting Future Operating Results

         The  Company's  operating  results  are  subject  to  general  economic
conditions and a variety of risks  characteristic of the semiconductor  industry
(including booking and shipment  uncertainties,  wafer supply fluctuations,  and
price  erosion)  or  specific  to the  Company,  any of which  could  cause  the
Company's  operating  results  to differ  materially  from past  results.  For a
discussion of such risks,  see "Risk Factors" in Part I of the Company's  Annual
Report on Form 10-K for 1999, which is incorporated herein by this reference.

Item 3.       Quantitative and Qualitative Disclosures About Market Risk

         As of October 1, 2000,  the Company's  investment  portfolio  consisted
primarily of corporate  bonds,  floating  rate notes,  and federal and municipal
obligations.  The primary objectives of the Company's investment  activities are
to preserve principal,  meet liquidity needs, and maximize yields. To meet these
objectives, the Company invests only in high credit quality debt securities with
average  maturities  of less  than  two  years.  The  Company  also  limits  the
percentage  of  total  investments  that  may be  invested  in any  one  issuer.
Corporate investments as a group are also limited to a maximum percentage of the
Company's investment portfolio.

         The  Company's  investments  are  subject to  interest  rate  risk.  An
increase in interest  rates could subject the Company to a decline in the market
value of its  investments.  These  risks are  mitigated  by the  ability  of the
Company to hold these  investments to maturity.  A hypothetical  100 basis point
increase  in  interest  rates  would  result  in  a  decrease  of  approximately
$1,371,000 in the fair value of the Company's available-for-sale securities.

         The  Company  purchases  a portion of the wafers it uses in  production
from  Japanese  suppliers,  which are  denominated  in Japanese  yen. An adverse
change in the foreign  exchange rate would affect the price the Company pays for
a portion of the wafers  used in  production  over the long  term.  The  Company
attempts to mitigate its exposure to risks from foreign currency fluctuations by
purchasing forward foreign exchange contracts to hedge firm purchase commitments
denominated in foreign currencies. Forward exchange contracts are short term and
do not hedge  purchases  that  will be made for  anticipated  longer-term  wafer
needs. A hypothetical  adverse change of 10% in exchange rates would result in a
decline in income before taxes of  approximately  $1,153,000  based on projected
yen denominated wafer purchases for the next four quarters.

         Both of the hypothetical changes noted above are based upon sensitivity
analysis  performed  on the  Company's  financial  position  at October 1, 2000.
Actual results may differ materially.



<PAGE>



Additional Quarterly Information

         The following table presents certain  unaudited  quarterly  results for
each of the eight  quarters in the period ended  October 1, 2000. In the opinion
of management,  all necessary  adjustments  (consisting only of normal recurring
accruals)  have been included in the amounts  stated below to present fairly the
unaudited   quarterly   results  when  read  in  conjunction  with  the  audited
consolidated  financial  statements of the Company and notes thereto included in
the  Company's  Annual  Report on Form 10-K for the year ended  January 2, 2000.
These quarterly operating results are not necessarily  indicative of the results
for any future period.

<TABLE>
<CAPTION>
                                                                              Three Months Ended
                                                 -----------------------------------------------------------------------------
                                                 Oct. 1,   Jul. 2,   Apr. 2,   Jan. 2,   Oct. 3,   Jul. 4,   Apr. 4,   Jan. 3,
                                                   2000      2000      2000      2000      1999      1999      1999      1999
                                                 -------   -------   -------   -------   -------   -------   -------   -------
                                                                      (in thousands, except per share amounts)
<S>                                              <C>       <C>       <C>       <C>       <C>       <C>       <C>       <C>
Statements of Income Data:
Net revenues .................................   $60,080   $55,544   $50,666   $46,042   $43,162   $41,619   $40,838   $40,174
Gross profit .................................    37,626    34,595    31,458    28,546    26,503    25,381    24,844    24,377
Income from operations .......................    13,648     6,778    10,555     7,175     7,492     2,111     5,466     5,535
Net income ...................................   $ 9,779   $20,112   $ 8,099   $ 5,823   $ 5,668   $ 1,926   $ 4,221   $ 4,118
Net income per share:
   Basic .....................................   $  0.41   $  0.86   $  0.36   $  0.26   $  0.26   $  0.09   $  0.20   $  0.20
                                                 =======   =======   =======   =======   =======   =======   =======   =======
   Diluted ...................................   $  0.36   $  0.77   $  0.32   $  0.24   $  0.25   $  0.09   $  0.19   $  0.19
                                                 =======   =======   =======   =======   =======   =======   =======   =======
Shares used in computing net income per share:
   Basic .....................................    23,869    23,263    22,767    22,048    21,748    21,511    21,347    21,091
                                                 =======   =======   =======   =======   =======   =======   =======   =======
   Diluted ...................................    26,999    26,186    25,467    24,015    23,003    22,454    22,673    22,201
                                                 =======   =======   =======   =======   =======   =======   =======   =======
</TABLE>

<TABLE>
<CAPTION>
                                                                              Three Months Ended
                                                 -----------------------------------------------------------------------------
                                                 Oct. 1,   Jul. 2,   Apr. 2,   Jan. 2,   Oct. 3,   Jul. 4,   Apr. 4,   Jan. 3,
                                                   2000      2000      2000      2000      1999      1999      1999      1999
                                                 -------   -------   -------   -------   -------   -------   -------   -------
<S>                                               <C>       <C>       <C>       <C>       <C>       <C>       <C>       <C>
As a Percentage of Net Revenues:
Net revenues .................................    100.0%    100.0%    100.0%    100.0%    100.0%    100.0%    100.0%    100.0%
Gross profit .................................     62.6      62.3      62.1      62.0      61.4      61.0      60.8      60.7
Income from operations .......................     22.7      12.2      20.8      15.6      17.4       5.1      13.4      13.8
Net income ...................................     16.3      36.2      16.0      12.6      13.1       4.6      10.3      10.3
</TABLE>


<PAGE>



                          PART II -- OTHER INFORMATION

Item 1.       Legal Proceedings

         Periodically,  the  Company is made aware that  technology  used by the
Company may infringe  intellectual  property  rights held by others.  During the
third quarter of fiscal 2000, the Company continued in negotiations with several
third parties regarding  potential patent  infringement  issues. The Company has
made adequate provision for the estimated settlement costs of claims for alleged
infringement  prior to the balance sheet date.  While  management  believes that
reasonable  resolution  will occur,  there can be no assurance that these claims
will be  resolved  or that  the  resolution  of  these  claims  will  not have a
materially  adverse effect on future results of operations or require changes in
the Company's products or processes. In addition, management's evaluation of the
likely impact of these pending  disputes could change based upon new information
learned by management. Subject to the foregoing, management does not believe any
pending dispute,  including the legal proceeding  described below, are likely to
have a materially adverse effect on the Company's financial  condition,  results
of  operations,  or  liquidity.  The  foregoing is a  forward-looking  statement
subject to all of the risks and uncertainties of intellectual  property disputes
and  legal   proceedings,   including  the  discovery  of  new  information  and
unpredictability as to the ultimate outcome.

         Except as described below,  there are no pending legal proceedings of a
material  nature to which the Company is a party or of which any of its property
is the subject.  There are no such legal  proceedings known by the Company to be
contemplated by any governmental authority.

         Unisys v. Actel and QuickLogic (CV C-00 01114 WDB)

         On March 29, 2000,  Unisys  brought suit in the United States  District
Court for the Northern  District of California,  San Jose Division,  against the
Company seeking monetary damages and injunctive  relief based on Actel's alleged
infringement of four patents held by Unisys. In the lawsuit, Unisys alleges that
the Company has  infringed  and  continues to infringe  four Unisys  patents and
seeks damages,  costs and attorneys' fees, as well as an injunction  prohibiting
further  infringement.  On May 11,  2000,  the  Company  filed  its  answer  and
counterclaim  in which it denies that it has infringed or is  infringing  any of
the asserted patents, and seeks a judicial declaration that the asserted patents
are invalid and unenforceable. Trial has been set to commence on March 25, 2002.
The Company believes that it has meritorious  defenses to the claims asserted by
Unisys and intends to defend itself vigorously in this matter.

Item 6.       Exhibits and Reports on Form 8-K

(a)      Exhibits

                  None

         (b)      Reports on Form 8-K

                  None

                                    SIGNATURE

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned thereunto duly authorized.



                                                        ACTEL CORPORATION




           Date: November 8, 2000                     /s/ Henry L. Perret
                                                --------------------------------
                                                         Henry L. Perret
                                                    Vice President of Finance
                                                   and Chief Financial Officer
                                                 (as principal financial officer
                                                   and on behalf of Registrant)


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission